£75.07

Springer The Chick Embryo Chorioallantoic Membrane in the Study of Angiogenesis and Metastasis: The CAM assay in the study of angiogenesis and metastasis

Price data last checked 101 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£75 today · usual range £0–£0 · best ever £71

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 630 days • 630 data points (No recent data available)

Historical
Generating forecast...
£75.25 £70.26 £71.35 £72.44 £73.52 £74.61 £75.70 10 June 2024 14 November 2024 20 April 2025 24 September 2025 01 March 2026

Price Distribution

Price distribution over 630 days • 5 price levels

Days at Price
Current Price
262 days 44 days 162 days 22 days 140 days · current 0 66 131 197 262 £71 £72 £73 £74 £75 Days at Price

Price Analysis

Most common price: £71 (262 days, 41.6%)

Price range: £71 - £75

Price levels: 5 different prices over 630 days

Description

As pointed out by Auerbach in 1991 "Perhaps the most consistent limitation to progress in angiogenesis research has been the availability of simple, reliable, reproducible, quantitative assays of the angiogenesis response." In vitro angiogenesis assays, based on endothelial cell cultures or tissue explant, focus on isolated endothelial cell functions (e.g., endothelial cell proliferation, migration, or invasion) and do not examine the coordination of cell functions required for a successful angiogenic response (Jain et al., 1997; Auerbach et al., 2000). Although in vitro angiogenesis assays have been useful for identi cation of potential molecular targets to block endothelial cell responses and preliminary screening of novel pharmacological agents, they frequently cannot be correlated with in vivo angiogenesis measurements. This is most likely the result of the c- plex and multiple cellular mechanism evoked during new blood vessel formation in vivo. In vitro assays cannot be considered conclusive and the activity of a compound must be con rmed in other assays of increasing complexity, including in vivo assays of angiogenesis, angiogenic-dependent tumor growth, and metastasis. From the Back Cover The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane which serves as a gas exchange surface and its function is supported by a dense capillary network. Because of its extensive vascularization and easy accessibility, the CAM has been broadly used to study the morpho-functional aspects of the angiogenesis process in vivo and to investigate the efficacy and mechanisms of action of pro-angiogenic and anti-angiogenic natural and synthetic molecules. The CAM is a suitable site for transplanting tissues, which can survive and develop in the CAM by peripheral anastomoses between graft and original CAM vasculature or by new angiogenic vessels grown from the CAM that invade the graft. While the formation of peripheral anastomoses between host and pre-existing donor vessels is the main, and the most common, mechanism involved in the revascularization of embryonic grafts, the growth of CAM-derived vessels into the graft is only stimulated in tumor grafts. The CAM has long been a favored system for the study of tumor angiogenesis and metastasis, because at this stage the chick immunocompetence system is not fully developed and the conditions for rejection have not been established. Tumors remain avascular for 72 h, after which they are penetrated by new blood vessels and begin a phase of rapid growth. Also, delivery of tumor cells onto the CAM allows the fine study of the effects of tumor derived angiogenic growth factors on blood vessel structure and functionality. The CAM may also used to verify the ability to inhibit the growth of capillaries by implanting tumors onto the CAM and by comparing tumor growth and vascularization with or without the administration of an anti-angiogenic molecule. Other studies using the tumor cells/CAM model have focused on the invasion of the chorionic epithelium and the blood vessels by tumor cells. The cells invade the epithelium and the mesenchymal connective tissue below, where they are found in the form of a dense bed of blood vessels, which is a target for intravasation.

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
28 February 2010
Listed Since
08 October 2009

Barcode

No barcode data available

Similar Products You Might Like

TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease: 64 (Results and Problems in Cell Differentiation, 64)
97% match

TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease: 64 (Results and Problems in Cell Differentiation, 64)

Springer

£117.14 15 Dec 2025
Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury
96% match

Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury

Springer

£147.73 04 Apr 2026
Tissue Stiffness as a Risk of Cancer Development and Impact on Clinical Outcome in Solid Tumors: A Systematic Review (Cancer Etiology, Diagnosis and Treatments)
96% match

Tissue Stiffness as a Risk of Cancer Development and Impact on Clinical Outcome in Solid Tumors: A Systematic Review (Cancer Etiology, Diagnosis and Treatments)

£203.99 10 Mar 2026
Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)
96% match

Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Springer

£75.66 01 Mar 2026
Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury
96% match

Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury

Springer

£113.39 04 Apr 2026
Stem Cells and Cancer Stem Cells, Volume 13: Therapeutic Applications in Disease and Injury
96% match

Stem Cells and Cancer Stem Cells, Volume 13: Therapeutic Applications in Disease and Injury

Springer

£73.85 29 Mar 2026
Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)
96% match

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Humana

£74.07 07 Mar 2026
Springer Cell Biology and Translational Medicine Volume 12
96% match

Springer Cell Biology and Translational Medicine Volume 12

Springer

£123.54 19 Apr 2026
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)
96% match

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Springer

£110.00 10 Mar 2026
New Developments in Tissue Engineering and Regeneration: 51 (Computational Methods in Applied Sciences, 51)
96% match

New Developments in Tissue Engineering and Regeneration: 51 (Computational Methods in Applied Sciences, 51)

Springer

£68.80 25 Feb 2026
Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)
96% match

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Springer

£128.11 19 Apr 2026
TGF-β Signaling: Methods and Protocols: 1344 (Methods in Molecular Biology, 1344)
96% match

TGF-β Signaling: Methods and Protocols: 1344 (Methods in Molecular Biology, 1344)

Humana

£115.72 09 Mar 2026
TGF-β Signaling: Methods and Protocols: 1344 (Methods in Molecular Biology, 1344)
96% match

TGF-β Signaling: Methods and Protocols: 1344 (Methods in Molecular Biology, 1344)

Humana

£79.93 15 Feb 2026
Humana Brain Organoid Research: 189 (Neuromethods, 189)
96% match

Humana Brain Organoid Research: 189 (Neuromethods, 189)

Humana

£102.87 18 Apr 2026
Stem Cells: From Mechanisms to Technologies
96% match

Stem Cells: From Mechanisms to Technologies

World Scientific Publishing Company

£73.00 08 Mar 2026
The TNF Superfamily: Methods and Protocols: 1155 (Methods in Molecular Biology, 1155)
96% match

The TNF Superfamily: Methods and Protocols: 1155 (Methods in Molecular Biology, 1155)

Humana

£72.56 04 Apr 2026
Advances in Medicine and Medical Research: 1133 (Advances in Experimental Medicine and Biology, 1133)
96% match

Advances in Medicine and Medical Research: 1133 (Advances in Experimental Medicine and Biology, 1133)

Springer

£74.35 08 Mar 2026
Advances in Medicine and Medical Research: 1133 (Advances in Experimental Medicine and Biology, 1133)
96% match

Advances in Medicine and Medical Research: 1133 (Advances in Experimental Medicine and Biology, 1133)

Springer

£72.62 20 Feb 2026
Ultrastructure Atlas of Human Tissues
96% match

Ultrastructure Atlas of Human Tissues

Wiley

£137.00 08 Feb 2026
Intercellular Communication in Cancer
96% match

Intercellular Communication in Cancer

Springer

£103.81 08 Mar 2026
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)
96% match

Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)

Springer

£125.98 11 Jan 2026
Academic Press iPSCs - State of the Science Volume 16
96% match

Academic Press iPSCs - State of the Science Volume 16

Academic Press

£116.98 18 Apr 2026
The TNF Superfamily: Methods and Protocols: 1155 (Methods in Molecular Biology, 1155)
96% match

The TNF Superfamily: Methods and Protocols: 1155 (Methods in Molecular Biology, 1155)

Humana

£74.07 10 Mar 2026
Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology (Cancer Drug Discovery and Development)
96% match

Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology (Cancer Drug Discovery and Development)

Humana

£163.53 20 Jan 2026